Infectious Disease clinical trials

Explore recruiting infectious disease clinical trials.

Recruiting infectious disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Infectious Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Real-world effectiveness, safety and immunogenicity of chikungunya vaccination in populations at risk of severe or complicated forms: an ambispective study in La Réunion

France

Therapeutic use (Phase IV) EU CTIS Study details

Evaluation of the Pharmacokinetics of Subcutaneous Administration of Piperacillin/Tazobactam: An Open-Label, Multicentric, Non-Inferiority Randomized Clinical Trial (STUPITA01)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized trial of tacrolimus monotherapy compared to standard triple immune suppressive medication in elderly recipients of a kidney transplant to reduce infection-related mortality and improve quality of life; the TACMONO-XL study.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Glucocorticoids versus placebo for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a randomized controlled trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A non-inferiority, randomised and controlled trial to compare the safety, tolerability and preliminary efficacy between standard and Torque Teno virus-guided immunosuppression in stable adult kidney transplant recipients with low immunological risk in the first year after transplantation

Netherlands, Czechia, France, Austria, Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A study to learn about how much emodepside gets absorbed in the blood and how food affects its absorption when given as a new type of tablet to healthy participants

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Infectious Disease trials by city

Infectious Disease in Toronto Infectious Disease in Vancouver Infectious Disease in Montreal Infectious Disease in Calgary Infectious Disease in Edmonton Infectious Disease in Ottawa Infectious Disease in Winnipeg Infectious Disease in Quebec City Infectious Disease in Hamilton Infectious Disease in Kitchener Infectious Disease in London Infectious Disease in Halifax Infectious Disease in New York Infectious Disease in Los Angeles Infectious Disease in Chicago Infectious Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease